Publications and Presentations

»Publications and Presentations
Publications and Presentations2018-05-22T20:54:44+00:00


  1. Gordon, L et al. “Association of Lonafarnib Treatment vs No Treatment with Mortality Rate in Patients with Hutchinson-Gilford Progeria Syndrome,” JAMA, 2018, 319(16):1687-1695. (click to view PDF)
  2. Gordon, L et al. “Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome,” Circulation. 2014;130:27-34. (click to view PDF)
  3. Gordon, L. et al. “Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome,” Circulation. 2016;134:114–125. (click to view PDF)
  4. Gordon, L et al. “Clinical Trial of a Farnesyltransferase Inhibitor in Children with Hutchinson-Gilford Progeria Syndrome,” Proceedings of the National Academy of Sciences of the United States of America. 2012:109:16666-16671. (click to view PDF)


Coming soon.

Hutchinson-Gilford Progeria Syndrome (Progeria)

Photos Courtesy of The Progeria Research Foundation